Janux Therapeutics Statistics
Total Valuation
JANX has a market cap or net worth of $1.37 billion. The enterprise value is $378.37 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JANX has 59.18 million shares outstanding. The number of shares has increased by 24.21% in one year.
Current Share Class | 59.18M |
Shares Outstanding | 59.18M |
Shares Change (YoY) | +24.21% |
Shares Change (QoQ) | +8.73% |
Owned by Insiders (%) | 6.63% |
Owned by Institutions (%) | 85.73% |
Float | 37.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 138.56 |
Forward PS | 1,740.96 |
PB Ratio | 1.33 |
P/TBV Ratio | 1.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 40.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 58.47, with a Debt / Equity ratio of 0.02.
Current Ratio | 58.47 |
Quick Ratio | 58.26 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.32% and return on invested capital (ROIC) is -8.28%.
Return on Equity (ROE) | -9.32% |
Return on Assets (ROA) | -8.16% |
Return on Invested Capital (ROIC) | -8.28% |
Return on Capital Employed (ROCE) | -10.99% |
Revenue Per Employee | $115,259 |
Profits Per Employee | -$959,778 |
Employee Count | 81 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.83% in the last 52 weeks. The beta is 2.95, so JANX's price volatility has been higher than the market average.
Beta (5Y) | 2.95 |
52-Week Price Change | -41.83% |
50-Day Moving Average | 26.28 |
200-Day Moving Average | 39.88 |
Relative Strength Index (RSI) | 41.07 |
Average Volume (20 Days) | 701,303 |
Short Selling Information
The latest short interest is 10.61 million, so 17.93% of the outstanding shares have been sold short.
Short Interest | 10.61M |
Short Previous Month | 10.67M |
Short % of Shares Out | 17.93% |
Short % of Float | 28.63% |
Short Ratio (days to cover) | 11.13 |
Income Statement
In the last 12 months, JANX had revenue of $9.34 million and -$77.74 million in losses. Loss per share was -$1.37.
Revenue | 9.34M |
Gross Profit | -70.04M |
Operating Income | -113.58M |
Pretax Income | -44.05M |
Net Income | -77.74M |
EBITDA | -111.54M |
EBIT | -113.58M |
Loss Per Share | -$1.37 |
Full Income Statement Balance Sheet
The company has $1.01 billion in cash and $22.61 million in debt, giving a net cash position of $991.53 million or $16.76 per share.
Cash & Cash Equivalents | 1.01B |
Total Debt | 22.61M |
Net Cash | 991.53M |
Net Cash Per Share | $16.76 |
Equity (Book Value) | 1.01B |
Book Value Per Share | 17.11 |
Working Capital | 1.01B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$46.00 million and capital expenditures -$533,000, giving a free cash flow of -$46.53 million.
Operating Cash Flow | -46.00M |
Capital Expenditures | -533,000 |
Free Cash Flow | -46.53M |
FCF Per Share | -$0.79 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,216.61% |
Pretax Margin | -832.71% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
JANX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.21% |
Shareholder Yield | -24.21% |
Earnings Yield | -5.67% |
FCF Yield | -3.40% |
Analyst Forecast
The average price target for JANX is $94.29, which is 307.30% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $94.29 |
Price Target Difference | 307.30% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 98.97% |
EPS Growth Forecast (5Y) | -20.89% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
JANX has an Altman Z-Score of 38.66 and a Piotroski F-Score of 1.
Altman Z-Score | 38.66 |
Piotroski F-Score | 1 |